Skip to main content

Zura Bio Ltd

ZURA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001855644

No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Zura Bio Ltd changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of ZURA: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders87174−12
Shares42.9M59.0K45.7M+2.88M (+6.7%)
Value$107.2M$147.4K$59.0M−$48.1M (−44.9%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Zura Bio Ltd at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to ZURA in Q1 2025
InstitutionSharesValue% of portfolio
Nuveen, LLC58,961$76.1K0.00%
AQR Capital Management LLC55,702$71.9K0.00%
CIBC World Markets Corp11,200$14.4K0.00%
FNY Investment Advisers, LLC5,000$6.00K0.00%
Jones Financial Companies LLLP1,369$1.73K0.00%
EverSource Wealth Advisors, LLC127$1640.00%
True Wealth Design, LLC95$1230.00%

Sold out (19)

Institutions that held Zura Bio Ltd at the end of Q4 2024 and filed for Q1 2025 without it.

Not filed for Q1 2025 yet (1)

Institutions that held Zura Bio Ltd at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ZURA in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC58,961$147.4K